Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
07 04 2022
Historique:
received: 14 12 2021
accepted: 23 03 2022
entrez: 8 4 2022
pubmed: 9 4 2022
medline: 12 4 2022
Statut: epublish

Résumé

Amniotic fluid embolism (AFE) is a rare but often catastrophic complication of pregnancy that leads to cardiopulmonary dysfunction and severe disseminated intravascular coagulopathy (DIC). Although few case reports have reported successful use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) with AFE, concerns can be raised about the increased bleeding risks with that device. This study included patients with AFE rescued by VA-ECMO hospitalized in two high ECMO volume centers between August 2008 and February 2021. Clinical characteristics, critical care management, in-intensive care unit (ICU) complications, and hospital outcomes were collected. ICU survivors were assessed for health-related quality of life (HRQL) in May 2021. During that 13-year study period, VA-ECMO was initiated in 54 parturient women in two high ECMO volume centers. Among that population, 10 patients with AFE [median (range) age 33 (24-40), SAPS II at 69 (56-81)] who fulfilled our diagnosis criteria were treated with VA-ECMO. Pregnancy evolved for 36 (30-41) weeks. Seven patients had a cardiac arrest before ECMO and two were cannulated under cardiopulmonary resuscitation. Pre-ECMO hemodynamic was severely impaired with an inotrope score at 370 (55-1530) μg/kg/min, a severe left ventricular ejection fraction measured at 14 (0-40)%, and lactate at 12 (2-30) mmol/L. 70% of these patients were alive at hospital discharge despite an extreme pre-ECMO severity and massive blood product transfusion. However, HRQL was lower than age-matched controls and still profoundly impaired in the role-physical, bodily pain, and general health components after a median of 44 months follow-up. In this rare per-delivery complication, our results support the use of VA-ECMO despite intense DIC and ongoing bleeding. Future studies should focus on customized, patient-centered, rehabilitation programs that could lead to improved HRQL in this population.

Sections du résumé

BACKGROUND
Amniotic fluid embolism (AFE) is a rare but often catastrophic complication of pregnancy that leads to cardiopulmonary dysfunction and severe disseminated intravascular coagulopathy (DIC). Although few case reports have reported successful use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) with AFE, concerns can be raised about the increased bleeding risks with that device.
METHODS
This study included patients with AFE rescued by VA-ECMO hospitalized in two high ECMO volume centers between August 2008 and February 2021. Clinical characteristics, critical care management, in-intensive care unit (ICU) complications, and hospital outcomes were collected. ICU survivors were assessed for health-related quality of life (HRQL) in May 2021.
RESULTS
During that 13-year study period, VA-ECMO was initiated in 54 parturient women in two high ECMO volume centers. Among that population, 10 patients with AFE [median (range) age 33 (24-40), SAPS II at 69 (56-81)] who fulfilled our diagnosis criteria were treated with VA-ECMO. Pregnancy evolved for 36 (30-41) weeks. Seven patients had a cardiac arrest before ECMO and two were cannulated under cardiopulmonary resuscitation. Pre-ECMO hemodynamic was severely impaired with an inotrope score at 370 (55-1530) μg/kg/min, a severe left ventricular ejection fraction measured at 14 (0-40)%, and lactate at 12 (2-30) mmol/L. 70% of these patients were alive at hospital discharge despite an extreme pre-ECMO severity and massive blood product transfusion. However, HRQL was lower than age-matched controls and still profoundly impaired in the role-physical, bodily pain, and general health components after a median of 44 months follow-up.
CONCLUSION
In this rare per-delivery complication, our results support the use of VA-ECMO despite intense DIC and ongoing bleeding. Future studies should focus on customized, patient-centered, rehabilitation programs that could lead to improved HRQL in this population.

Identifiants

pubmed: 35392980
doi: 10.1186/s13054-022-03969-3
pii: 10.1186/s13054-022-03969-3
pmc: PMC8988404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

96

Informations de copyright

© 2022. The Author(s).

Références

Obstet Gynecol Surv. 1990 Jun;45(6):360-8
pubmed: 2195407
Intensive Care Med. 2013 Oct;39(10):1704-13
pubmed: 23907497
Lancet. 2020 Aug 22;396(10250):545-552
pubmed: 32828186
J Clin Endocrinol Metab. 2002 Jul;87(7):3118-24
pubmed: 12107211
Curr Opin Anaesthesiol. 2019 Apr;32(2):234-241
pubmed: 30817400
Pediatr Crit Care Med. 2011 Mar;12(2):133-6
pubmed: 20453704
Am J Obstet Gynecol. 1986 Jan;154(1):104-6
pubmed: 2418682
Am J Obstet Gynecol. 2016 Oct;215(4):408-12
pubmed: 27372270
BMC Pregnancy Childbirth. 2021 Nov 16;21(1):776
pubmed: 34784887
Eur J Obstet Gynecol Reprod Biol. 2015 Feb;185:88-95
pubmed: 25541530
Am J Obstet Gynecol. 2014 Jul;211(1):32.e1-9
pubmed: 24631705
ASAIO J. 2021 Aug 1;67(8):827-844
pubmed: 34339398
Crit Care. 2017 Mar 28;21(1):76
pubmed: 28347320
Am J Obstet Gynecol. 2016 Aug;215(2):B16-24
pubmed: 26987420
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
J Clin Epidemiol. 1998 Nov;51(11):1013-23
pubmed: 9817119
Lancet. 2007 Oct 13;370(9595):1329-37
pubmed: 17933647
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901
pubmed: 25695688
Crit Care Med. 2011 May;39(5):1029-35
pubmed: 21336134
J Obstet Gynaecol Res. 2021 Sep;47(9):3374-3378
pubmed: 34132000
Psychosom Med. 1979 May;41(3):209-18
pubmed: 472086
Crit Care Explor. 2020 Jul 16;2(7):e0162
pubmed: 32766559
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Intensive Care Med. 2011 Nov;37(11):1738-45
pubmed: 21965097
Arch Womens Ment Health. 2018 Jun;21(3):341-351
pubmed: 29256069
BMC Pregnancy Childbirth. 2012 Feb 10;12:7
pubmed: 22325370
Crit Care Med. 2012 Jul;40(7):2059-63
pubmed: 22584758
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Int J Cardiol. 2020 Jul 15;311:71-76
pubmed: 32321653

Auteurs

Sarah Aissi James (S)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Thomas Klein (T)

Université de Lorraine, CHRU de Nancy, Institut Lorrain du Cœur Et Des Vaisseaux, Service de Médecine Intensive-Réanimation, U1116, FCRIN-INICRCT, Nancy, France.

Guillaume Lebreton (G)

Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.
Service de Chirurgie Cardiaque, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Jacky Nizard (J)

Department of Gynaecology and Obstetrics, Groupe Hospitalier Pitié-Salpêtrière, CNRS UMR 7222, INSERM U1150, Sorbonne Universités, Paris, France.

Juliette Chommeloux (J)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.

Nicolas Bréchot (N)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.

Marc Pineton de Chambrun (M)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.

Guillaume Hékimian (G)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.

Charles-Edouard Luyt (CE)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.

Bruno Levy (B)

Université de Lorraine, CHRU de Nancy, Institut Lorrain du Cœur Et Des Vaisseaux, Service de Médecine Intensive-Réanimation, U1116, FCRIN-INICRCT, Nancy, France.

Antoine Kimmoun (A)

Université de Lorraine, CHRU de Nancy, Institut Lorrain du Cœur Et Des Vaisseaux, Service de Médecine Intensive-Réanimation, U1116, FCRIN-INICRCT, Nancy, France.

Alain Combes (A)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France.
Sorbonne Université, GRC 30, RESPIRE, Assistance Publique-Hôpitaux de Paris (APHP) Hôpital Pitié-Salpêtrière, Paris, France.

Matthieu Schmidt (M)

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, 75013, Paris, France. matthieu.schmidt@aphp.fr.
Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, 75013, Paris, France. matthieu.schmidt@aphp.fr.
Sorbonne Université, GRC 30, RESPIRE, Assistance Publique-Hôpitaux de Paris (APHP) Hôpital Pitié-Salpêtrière, Paris, France. matthieu.schmidt@aphp.fr.
Service de Medecine Intensive Reanimation, iCAN, Institute of Cardiometabolism and Nutrition, Hôpital de la Pitié-Salpêtrière, 47, bd de l'Hôpital, 75651, Paris Cedex 13, France. matthieu.schmidt@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH